Good Morning America
Brooke Nelson said she was over 200 pounds and struggling to lose weight when she decided to take part in a clinical trial of a new, minimally-invasive weight loss procedure. The procedure Nelson underwent is called endoscopic ablation, which the lead author of the clinical trial, Dr. Christopher McGowan, says targets ghrelin, the so-called "hunger hormone." According to McGowan, an obesity medicine, internal medicine, and gastroenterology specialist, the procedure involves inserting a camera into the patient's stomach while fluids are administered to protect the underlying stomach tissue.